🟢 Eupraxia Pharmaceuticals is trading 13.78% up today in pre-market with no clear company-specific catalyst identified

Eupraxia Pharmaceuticals is trading 13.78% up at $7.35 after no clear company-specific catalyst was identified for September 1, 2026.

• No September 1 announcement appears on the company’s release calendar; its latest updates were August 11 financial results and August 13 RESOLVE data.
• Broader markets were weaker, so global sentiment does not clearly explain this opposite-direction move.